Provenance-centered dataset of drug-drug interactions

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 9367, Issue , 2015, Pages 293-300

  Banda, Juan M ^a   Kuhn, Tobias ^b,c   Shah, Nigam H ^a   Dumontier, Michel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ETH ZURICH   (Switzerland)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Data mining; Drug drug interactions; Nanopublications

Indexed keywords

DATA MINING; DECISION MAKING; MAPPING; SEMANTIC WEB;

DRUG-DRUG INTERACTIONS; ELECTRONIC HEALTH RECORD; EXTERNAL RESOURCES; MULTIPLE SOURCE; NANOPUBLICATION; NANOPUBLICATIONS; PREDICTION METHODS; PUBLIC DATABASE;

DRUG INTERACTIONS;

EID: 84952647971     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-319-25010-6_18     Document Type: Conference Paper

References (20)

1. Avillach, P., Dufour, J.-C., Diallo, G., Salvo, F., Joubert, M., Thiessard, F., Mougin, F., Trifirò, G., Fourrier-Réglat, A., Pariente, A., Fieschi, M.: Design and validation of an automated method to detect known adverse drug reactions in medline: a contribution from the eu–adr project. Journal of the American Medical Informatics Association 20(3), 446–452 (2013)
2. Banda, J.M., Kuhn, T., Shah, N.H., Dumontier, M.: Liddi: Provenance-centered dataset of drug-drug interactions. figshare July 17, 2015. http://dx.doi.org/10.6084/m9.figshare.1486478
3. Bushardt, R.L., Massey, E.B., Simpson, T.W., Ariail, J.C., Simpson, K.N.: Polypharmacy: Misleading, but manageable. Clinical Interventions in Aging. 3(2), 383–389 (2008). 18686760[pmid] Clin Interv Aging
4. Callahan, A., Cruz-Toledo, J., Ansell, P., Dumontier, M.: Bio2RDF release 2: improved coverage, interoperability and provenance of life science linked data. In: Cimiano, P., Corcho, O., Presutti, V., Hollink, L., Rudolph, S. (eds.) ESWC 2013. LNCS, vol. 7882, pp. 200–212. Springer, Heidelberg (2013)
5. Dumontier, M., Baker, C.J., Baran, J., Callahan, A., Chepelev, L.L., Cruz-Toledo, J., Nicholas, R., Rio, D., Duck, G., Furlong, L.I., et al.: The semanticscience integrated ontology (sio) for biomedical research and knowledge discovery. J. Biomedical Semantics 5, 14 (2014)
6. Gottlieb, A., Stein, G.Y., Oron, Y., Ruppin, E., Sharan, R.: Indi: a computational framework for inferring drug interactions and their associated recommendations. Molecular Systems Biology 8, 592–592 (2012). 22806140[pmid] Mol. Syst. Biol
7. Groth, P., Gibson, A., Velterop, J.: The anatomy of a nano-publication. Information Services and Use 30(1), 51–56 (2010)
8. Haerian, K., Varn, D., Vaidya, S., Ena, L., Chase, H.S., Friedman, C.: Detection of pharmacovigilance-related adverse events using electronic health records and automated methods. Clinical pharmacology and therapeutics 92(2), 228–234 (2012)
9. Iyer, S.V., Harpaz, R., LePendu, P., Bauer-Mehren, A., Shah, N.H.: Mining clinical text for signals of adverse drug-drug interactions. J. Am. Med. Inform. Assoc. 21(2), 353–362 (2014)
10. T. Kuhn, C. Chichester, M. Krauthammer, and M. Dumontier. Publishing without publishers: a decentralized approach to dissemination, retrieval, and archiving of data. In: Proceedings of ISWC 2015. Lecture Notes in Computer Science. Springer (2015)
11. Kuhn, T., Dumontier, M.: Trusty URIs: verifiable, immutable, and permanent digital artifacts for linked data. In: Presutti, V., d’Amato, C., Gandon, F., d’Aquin, M., Staab, S., Tordai, A. (eds.) ESWC 2014. LNCS, vol. 8465, pp. 395–410. Springer, Heidelberg (2014)
12. Kuhn, T., Dumontier,M.: Making digital artifacts on the web verifiable and reliable. IEEE Transactions on Knowledge and Data Engineering (2015)
13. Lazarou, J., Pomeranz, B.H., Corey, P.N.: Incidence of adverse drug reactions in hospitalized patients:Ameta-analysis of prospective studies. JAMA 279(15), 1200–1205 (1998). doi:10.1001/jama.279.15.1200
14. Lebo, T., et al.: PROV-O: The PROV ontology. Recommendation, W3C (2013)
15. Mons, B., van Haagen, H., Chichester, C., den Dunnen, J.T., van Ommen, G., van Mulligen, E., Singh, B., Hooft, R., Roos, M., Hammond, J., et al.: The value of data. Nature genetics 43(4), 281–283 (2011)
16. Tatonetti, N.P., Ye, P.P., Daneshjou, R., Altman, R.B.: Data-driven prediction of drug effects and interactions. ScienceTranslational Medicine 4(125), 125ra31 (2012). doi:10.1126/scitranslmed.3003377
17. Vilar, S., Uriarte, E., Santana, L., Lorberbaum, T., Hripcsak, G., Friedman, C., Tatonetti, N.P.: Similarity-based modeling in large-scale prediction of drug-drug interactions. Nat. Protocols 9(9), 2147–2163 (2014)
18. Wishart, D.S., Knox, C., Guo, A.C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., Hassanali, M.: Drugbank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research 36, D901–D906 (2008). 18048412[pmid] Nucleic Acids Res
19. Zhang, L., Zhang, Y., Zhao, P., Huang, S.-M.: Predicting drugdrug interactions: An fda perspective. The AAPS Journal 11(2), 300–306 (2009)
20. Linked Drug-Drug Interactions (LIDDI) dataset. Nanopublication index, July 17, 2015. http://np.inn.ac/RA7SuQ0e661LJdKpt5EOS2DKykf1ht9LFmNaZtFSDMrXg